Related by context. All words. (Click for frequent words.) 78 Inventory BPI 71 Visual Analog Scale 69 Depressive Symptomatology 69 Visual Analog 69 Crohn Disease Activity 69 Visual Analogue Scale VAS 68 State Trait Anxiety 67 NIH CPSI 67 Fibromyalgia Impact Questionnaire 66 Brief Psychiatric 66 Index CDAI 65 non menstrual pelvic 65 Montgomery Åsberg Depression 65 Visual Analogue Scale 65 nasal symptom 65 Pain Intensity 65 YMRS 64 WOMAC 64 Health Assessment Questionnaire 64 Scale PANSS 64 Neuropsychiatric Inventory 64 Montgomery Asberg Depression 63 Alzheimer Disease Assessment 63 Clinician Administered PTSD 63 Rating Scale MADRS 63 HAM D# 63 pain subscale 63 Global Impression CGI 63 Negative Syndrome 63 PANSS 63 interobserver 63 Main Outcome Measures 63 Score DAS 63 Ocular Surface Disease 63 symptom severity 62 WOMAC pain 62 ADAS cog 62 MADRS 62 DAS# CRP 62 Severity MSCS score 62 Distress Scale 62 WAIS III 61 HADS 61 Geriatric Depression 61 ADCS ADL 61 Score IPSS 61 Rating Scale UPDRS 60 hepatic enzyme 60 subscores 60 Wechsler Adult 60 Female Sexual Function 60 Unified Parkinson Disease 60 State Examination MMSE 60 ADCS CGIC 60 Neuropsychiatric Inventory NPI 60 Hamilton Rating Scale 60 Primary endpoints 60 QIDS SR 60 Disease Activity 60 albumin excretion rate 60 Functioning GAF 60 Global Impression 60 erythrocyte sedimentation rate 60 Index WOMAC 60 Y BOCS 60 DAS# scores 60 Symptom severity 60 CDAI 60 urinary N telopeptide 59 Psoriasis Area 59 State Exam MMSE 59 Cystic Fibrosis Questionnaire Revised 59 nausea photophobia 59 Severity Index PASI 59 ADHD Rating Scale 59 Dyspnea 59 ADAS Cog 59 HOMA IR 59 Functional Assessment 59 Symptom Severity 59 Main Outcome Measure 59 left ventricular diastolic 59 IRLS 59 Likert pain 59 CDAI score 59 UPDRS 59 Pain Rating Scale 59 aspartate aminotransferase AST 59 bronchial hyperresponsiveness 59 Pharmacokinetic parameters 59 HAQ DI 59 OSDI 59 Subscale 59 Cardiorespiratory fitness 59 Pearson correlation coefficient 59 creatine kinase MB 59 subscale scores 59 spirometric 58 HAMD 58 MMSE 58 NPRS 58 oxycodone CR 58 McGill Pain Questionnaire 58 NIS LL 58 Comorbidity 58 activated partial thromboplastin 58 IBDQ 58 Creatinine 58 Preoperatively 58 urine albumin 58 SF #v# 58 SELENA SLEDAI 58 HDRS 58 EQ 5D 58 Severity Scale 58 Symptom Checklist 58 Index FSFI 58 Cronbach alpha 58 mg BID dose 58 Outcomes Study 58 correlation coefficients 58 Negative Symptoms 58 Erectile Function 58 subscore 58 Secondary endpoints included 58 Pharmacodynamic 58 subscales 57 CNS LS 57 Fasting plasma glucose 57 PANSS total 57 Complicated Grief 57 Skin sterol 57 erection hardness 57 MADRS score 57 Symptom Score 57 corticosteroid dose 57 MoxDuo TM IR 57 Beck Anxiety Inventory 57 nerve conduction velocity 57 Hamilton Anxiety Scale 57 Treatment Outcome 57 ARB telmisartan 57 Rating Scale BPRS 57 ASIA Impairment 57 Depressive Symptoms 57 Outcome Measures 57 Postoperative 57 Assessment Questionnaire 57 function subscales 57 serum urate 57 Lower Limb 57 wrist actigraphy 57 DAS# [002] 57 fructosamine 57 Rating Scale 57 FACIT Fatigue 57 -#.# mg dL [001] 57 4mg/kg 57 mineral density BMD 57 RECIST Response Evaluation Criteria 57 Score TOS 57 Scale EDSS 57 serum cortisol 57 STAI 57 Left Ventricular Ejection Fraction 57 dactylitis 57 EORTC QLQ C# 57 BMI z 57 Mania Rating Scale 56 semiquantitative 56 Mean Symptom Complex 56 brachial artery flow 56 psychometric properties 56 microvessel density 56 urinary albumin 56 Endothelial function 56 ACR# ACR# 56 eNO 56 CFQ R 56 dyspnoea 56 International Prostate Symptom 56 intraclass correlation coefficient 56 serum HBV DNA 56 #mg/day [001] 56 Seattle Angina Questionnaire 56 prospectively stratified 56 Numeric Rating Scale 56 Expanded Disability Status 56 Rating Scale IRLS 56 multivariate Cox 56 postprocedure 56 Oswestry Disability Index 56 confidence intervals CIs 56 transcranial Doppler ultrasound 56 Randomized Evaluation 56 glycosylated hemoglobin HbA1c 56 desvenlafaxine succinate 56 meta regression 56 Respiratory Symptoms 56 PCWP 56 morphometric vertebral fractures 56 calculated creatinine clearance 56 covariate 56 Secondary efficacy endpoints 56 vitreous haze 56 Tumor Response 56 Erectile Function IIEF 56 Loss Severity 56 secondary efficacy endpoint 56 NIHSS 56 interrater reliability 56 apnea hypopnea index 56 SBM frequency 56 Hopkins Symptom Checklist 56 Abnormal Involuntary Movement 56 Histologic 56 Tasigna prolongs 55 Myocardial Infarction TIMI 55 HAM D 55 Assessment Scale 55 -#.# log# copies mL 55 Insulin sensitivity 55 Sleep Disturbance 55 zonisamide SR 55 affective psychosis 55 Functional Capacity 55 C Reactive Protein 55 serum aminotransferase levels 55 CHADS2 55 Functional Outcomes 55 Severity Index 55 arterial oxygen saturation 55 WOMAC scores 55 PASI scores 55 epoetin alpha 55 glomerular filtration rate 55 MSLT 55 TNSS 55 mmHg diastolic 55 EF Domain 55 confirmed CCyR 55 daytime somnolence 55 UPDRS motor 55 Univariate 55 Scale cognitive subscale 55 Key secondary endpoints 55 clinically meaningful improvement 55 WOMAC TM 55 nausea emesis 55 Depression Inventory BDI 55 glomerular filtration 55 mean ± SEM 55 APACHE II 55 Glomerular Filtration Rate 55 Fracture Risk 55 Helps Relieve 55 Neuropsychological Status 55 electroencephalographic 55 PHQ 9 55 vitreous floaters 55 tapentadol ER 55 IRLS score 55 depressive symptom 55 Likert scale 55 extrapyramidal symptoms 55 BPRS 55 Score DAS# 55 intraobserver 55 Profile SEP 55 Anxiety Depression 55 lactate dehydrogenase LDH 55 CIBIC plus 55 Depression Inventory 55 demonstrated clinically meaningful 55 Negative Symptom Scale 55 cardiac autonomic 55 spontaneous bowel movements 55 aminotransferase levels 55 IPSS 55 Alanine 55 Hypercholesterolemia 55 mL/min/#.# m 2 55 PANSS Positive 55 Efficacy endpoints 55 creatinine clearance 55 apnea hypopnea 55 metabolite concentrations 54 haematologic 54 alanine aminotransferase ALT 54 moderate renal impairment 54 postinjury 54 laser Doppler 54 serum magnesium 54 Generalized Anxiety Disorder 54 Impressions Improvement 54 Endocrine Therapy 54 CSBM 54 Kaplan Meier method 54 aortic crossclamp 54 hepatic enzymes 54 intima media thickness IMT 54 Index CDAI score 54 Clinical Outcome 54 Chronic Illness Therapy 54 Ambulatory Blood Pressure 54 EBMT criteria 54 Secondary endpoints 54 aspartate aminotransferase 54 MCID 54 McMaster Universities Osteoarthritis 54 gadolinium enhancing 54 Forced Vital 54 Digit Symbol Substitution 54 lopinavir r arm 54 alanine aminotransferase 54 BILAG 54 mediated dilation 54 multiple linear regression 54 Scale Cognitive Subscale 54 postintervention 54 ratio WHR 54 Secondary endpoints include 54 point Likert scale 54 F FDG PET 54 nausea somnolence 54 coronary stenosis 54 microalbumin 54 mTSS 54 clinically meaningful reductions 54 overnight polysomnography 54 ropivacaine 54 QTcF 54 Multivariable 54 elevated ALT 54 Levels Linked 54 PSA kinetics 54 serum HCV RNA 54 ADHD RS 54 estimated glomerular filtration 54 endoscopic remission 54 Hemoglobin A1c 54 Wechsler Memory 54 â ‰ ¥ 54 hours postdose 54 Diabetic Foot Ulcer 54 fasting plasma 54 Rosenberg Self Esteem 54 endometrial thickness 54 SGOT 54 achieved statistical significance 54 DLQI 54 cerebral oxygenation 54 PANSS scores 54 Study ETDRS 54 hemodynamic parameters 54 Global Impression Severity 54 PSQI 54 serum bicarbonate 54 Scale EDSS score 54 Risk Stratification 54 NYHA functional class 54 Virologic Response 54 actigraphy 54 Persistent Sleep 54 serum CRP 54 ug kg 54 creatinine ratio 54 Depression Rating Scale 54 intraclass correlation coefficients 54 TLUS 53 Desvenlafaxine Succinate 53 MMSE score 53 Tiotropium 53 Albuminuria 53 FDG-PET/CT 53 Symptom 53 Significantly Reduces 53 logistic regression analysis 53 Myocardial Perfusion 53 cough dyspnea 53 induration 53 N telopeptide 53 creatine kinase 53 Acute Physiology 53 Sexual Satisfaction 53 QRS duration 53 serum triglycerides 53 Adverse Event 53 urate lowering therapy 53 multivariable Cox 53 Prolongs Survival 53 adenoma recurrence 53 subtests 53 Comorbidities 53 Ki# 53 hyperalgesia 53 ANCOVA 53 repeat paracentesis 53 posttreatment 53 interquartile range IQR 53 glycaemia 53 ACE Inhibitors 53 Depression Anxiety 53 Depression Scale 53 multiple logistic regression 53 Hippocampal 53 exploratory endpoints 53 retest reliability 53 anthropometric measures 53 Glomerular filtration rate 53 Treatment Diabetic Retinopathy 53 extrapyramidal side 53 lowest tertile 53 univariate 53 Cronbach 53 measured 53 Showed Significant 53 serum phosphorous 53 Orthostatic Hypotension 53 cortical atrophy 53 dyssynchrony 53 scores TNSS 53 premorbid 53 OGTT 53 maximal treadmill 53 pulmonary capillary wedge 53 Repeatable Battery 53 Atomoxetine 53 plasma cortisol 53 plasma HCV RNA 53 Quotient TM 53 Quantification 53 KOOS 53 IKDC 53 CRp 53 ALT AST 53 regression coefficient 53 interrater 53 ankle brachial 53 Thrombolysis 53 Epidemiological Studies Depression 53 Ischemic Stroke 53 Hb A1c 53 Significant Improvements 53 IIEF 53 Non Responders 53 Left Ventricular 53 enthesitis 53 leukocyte counts 53 μg liter 53 H2RAs 53 ALS Functional 53 PLMS 53 rhinoconjunctivitis 53 Impact Questionnaire 53 Physical Function 53 mean baseline A1C 53 Kaplan Meier survival 53 Ejection Fraction 53 EEG abnormalities 53 odds ratios ORs 53 Glasgow Coma Scale 53 Likert 53 Descriptive statistics 53 IELT 53 6MWD 53 Histological 53 exhaled nitric oxide 53 Timed Walk 53 aminotransferase 53 Physical Component 53 Magnetic Stimulation 53 Fasting blood glucose 53 AUA Symptom Score 53 Cystatin C 53 adjunctive placebo 53 serum bilirubin 53 bioavailable testosterone 53 CIMZIA TM certolizumab pegol 52 Mini Mental 52 unresectable HCC 52 rotigotine 52 lumbar spine BMD 52 Glycaemic 52 lactate dehydrogenase 52 hematological parameters 52 exhaled NO 52 hemoglobin A1c levels 52 ANOVA 52 atherogenic dyslipidemia 52 aPTT 52 bispectral index BIS 52 mL kg 52 NIHSS score 52 Novel Compound 52 Poisson regression 52 PSA nadir 52 achieved ACR# 52 Demonstrated Significant 52 opioid naïve 52 Epworth Sleepiness Scale 52 Stable Angina 52 #q# deletion syndrome 52 methotrexate monotherapy 52 Platelet counts 52 oral antidiabetic medication 52 inhibin B 52 #OHD 52 Inflammatory Pain 52 Myocardial 52 ug dose 52 fasting plasma glucose FPG 52 enzyme immunoassay EIA 52 GI motility 52 SGRQ 52 Postoperative Ileus 52 Likert scales 52 Edinburgh Postnatal Depression 52 oxygen desaturation 52 hemoglobin A1c HbA1c 52 Diastolic 52 LV ejection fraction 52 Lower Extremity 52 hematologic parameters 52 Relapsing Multiple Sclerosis 52 binary logistic regression 52 CCyR 52 chest radiographs 52 Statistically Significant 52 Pharmacodynamics 52 salivary cortisol 52 ETDRS 52 preoperatively 52 timepoint 52 Significantly Improved 52 Evaluable 52 akinesia 52 Ashworth Scale 52 Patency 52 convergent validity 52 CI -#.# 52 Renal Function 52 intact parathyroid hormone 52 Common Terminology Criteria 52 Coronary Artery Calcium 52 decrements 52 HRQL 52 mL/min/#.# m2 52 interobserver reliability 52 Patients Receiving 52 Ankle Brachial Index 52 PERMP 52 mm Hg diastolic 52 visceral adiposity 52 oral prednisolone 52 Data Extraction 52 XIENCE V PROMUS Stent 52 cognitive affective 52 depressive symptomatology 52 hip BMD 52 echocardiographic parameters 52 tracer uptake 52 ischemia driven 52 Electrophysiological 52 Repeatability 52 solifenacin 52 Postoperatively 52 HBV DNA levels 52 Cognitive Function 52 submaximal 52 Depressive symptoms 52 somatization 52 estimated GFR 52 Double Blind Randomized 52 AST ALT 52 divalproex sodium 52 DAS# remission 52 -#.# mg dL [002] 52 Reduced Risk 52 Symptom Scale 52 FDG PET scans 52 Placebo Controlled Trial 52 Wilcoxon rank sum 52 lumbar spine bone 52 total cholesterol triglycerides 52 Stress Induced 52 surgically resected 52 FSFI 52 expiratory flow 52 Hemodynamic 52 Kellgren Lawrence 52 LDL triglycerides 52 pretreatment serum 52 posterior cingulate 52 Excretion 52 timepoints 52 T2 lesion volume 52 CORE OM 52 Cytogenetic 52 posttest 52 International Normalized Ratio 52 neurologic dysfunction 52 CSBMs 52 covariance ANCOVA 52 Diagnostic Criteria 52 Improves Outcomes 52 Visual acuity 52 escitalopram Lexapro 52 Status Scale EDSS 52 Predict Risk 52 Univariate analysis 52 Stroke Scale 52 treat NNT 52 CIMZIA ™ 52 subsyndromal 52 prespecified secondary 52 undetectable HBV DNA 52 Ventricular Arrhythmias 52 exertional chest 51 logistic regression model 51 racemic albuterol 51 specific antigen PSA 51 pretreatment baseline 51 Kaplan Meier estimates 51 serum estradiol 51 asterisk denotes 51 serum lipid 51 Medication Adherence 51 correlated inversely 51 intradermal injections 51 cerebral oxygen saturation 51 glucose insulin 51 urinary albumin excretion 51 Child Behavior Checklist 51 serum PTH 51 neutropenia thrombocytopenia 51 Polysomnography 51 Kaplan Meier 51 Sensitivity Analysis 51 #.#/#.# mm Hg [003] 51 selective cerebral perfusion 51 SIMPADICO 51 serum homocysteine 51 transaminases 51 bortezomib refractory 51 UPDRS Part III 51 EURIDIS 51 insulin detemir 51 bivalirudin monotherapy 51 tissue oxygenation 51 Traveler Sentiment 51 nasal airflow 51 linaclotide treated 51 Meta Analysis 51 multivariable adjusted 51 symptomatic intracranial hemorrhage 51 baseline FEV 51 Coronary Artery Bypass Graft 51 blood Phe levels 51 Oral Fingolimod 51 glycated hemoglobin HbA1c 51 Capsules CII 51 tertiles 51 asthenia fatigue 51 NOAEL 51 comorbid depression 51 Virologic 51 Ishak fibrosis score 51 Stent Placement 51 radiographic progression 51 Adalimumab 51 hemodynamic measurements 51 intravascular hemolysis 51 CK MB 51 sUA levels 51 clinicopathological features 51 FDG uptake 51 meta analytic 51 aminotransferase ALT 51 Functioning Scale 51 plasma lipids 51 #.#/#.# mmHg [001] 51 lymphocyte count 51 Interrater reliability 51 Qmax 51 0mg 51 Apolipoprotein B 51 colorectal adenoma 51 HER2 expression 51 Angiographic 51 Kaplan Meier analysis 51 reactive hyperemia 51 icatibant 51 bepotastine besilate nasal spray 51 percutaneous vertebroplasty 51 Prostate Cancer Recurrence 51 Intrathecal 51 imipramine Tofranil 51 Somnolence 51 plasma leptin 51 pairwise comparisons 51 serum phosphate 51 plasma homocysteine 51 insulin resistance HOMA IR 51 Hypotension 51 carotid artery intima media 51 % Confidence Interval 51 LDL HDL 51 Demonstrates Significant 51 Tabulated 51 multicenter multinational 51 fatigue nausea vomiting 51 insomnia somnolence 51 intermittent dosing 51 Adenomas 51 covariance 51 electrophysiologic 51 ventricular repolarization 51 ITU algorithms PAMS 51 DQI 51 euthymic 51 mucosal inflammation 51 fasting serum 51 logistic regression analyzes 51 euthymic patients 51 interobserver agreement 51 Blood Pressure Monitoring 51 apolipoprotein B 51 endoscopic gastric ulcers 51 quantitative coronary angiography 51 Natural Catastrophe Stress 51 QRS width 51 SINAD 51 subjective sleepiness 51 Bipolar Disorder STEP BD 51 PLMs 51 Forced expiratory volume 51 protein excretion 51 Leukocyte 51 linear regression analysis 51 Apgar scores 51 ‰ ¥ 51 SCr 51 STRIDE PD 51 univariate analysis 51 Symptom Relief 51 serum folate concentrations 51 pressure monitoring ABPM 51 urodynamic studies 51 MERIT ES 51 hemoglobin Hb 51 corneal staining 51 serum ferritin 51 vasomotor 51 CI #.#-#.# [001] 51 serum leptin 51 dehydroepiandrosterone sulfate 51 Scale Revised 51 FACIT 51 variance ANOVA 51 tipranavir r 51 Epoetin Alfa 51 Anxiety Rating Scale 51 Platelet Aggregation 51 rCBF 51 Proteinuria 51 serologically active patients 51 log# copies mL 51 Tolerances 51 gadolinium enhancing lesions 51 Shows Efficacy 51 trials RCTs 51 linear regression analyzes 51 Clinical Relevance 51 fasting insulin 51 TIMP 1 51 Cardiac Resynchronization 51 3mg/kg 51 intratympanic 51 glycosylated hemoglobin levels 51 serum urate levels 51 rFSH 51 poststroke 51 SSRI citalopram 51 duplex ultrasonography 51 Quantified 51 AUC0 51 CrCl 51 serum glucose 51 weakly correlated 51 elevated LDH 51 endotoxin concentrations 51 QTc intervals 51 Neurocognitive 51 cTnT levels 51 Vertebral Fractures 51 diastolic pressures 51 Free Survival PFS 51 bivariate 51 Study Demonstrates 51 x ULN 51 Multivariate analysis revealed 51 Kruskal Wallis test 51 ± SEM 51 APTIVUS r 51 renal cortical 51 PESQ 51 mania hypomania 51 Erythropoiesis Stimulating Agents ESAs 51 mmHg systolic 51 parkinsonian 50 β blocker 50 Warfarin Coumadin 50 glycated hemoglobin 50 peak VO2 50 serum lactate 50 nonfatal MI 50 -#.# log# 50 VFQ 50 immunohistochemical analysis 50 postoperative radiographs 50 Myocardial Perfusion Imaging 50 Logistic Regression 50 Capacity FVC 50 fraction LVEF 50 Controlled Trial 50 waist circumference measurements 50 Shows Modest 50 Quantile 50 cortical activation 50 Cholinesterase Inhibitors 50 Hematocrit 50 RT qPCR 50 Subgroup analysis 50 Esomeprazole 50 P = .# 50 D Dimer 50 spine BMD 50 urinary cortisol 50 OSAHS 50 nonsignificant difference 50 Frequency Response 50 HRQOL 50 uL 50 ankle brachial index 50 calcaneal fractures 50 left ventricular LV 50 Anterior Cruciate Ligament Reconstruction 50 QIDS 50 Subgroup Analysis 50 Solid Tumors 50 waist circumference WC 50 STRATEGY FOR AN OPEN 50 Echocardiographic 50 Hepatotoxicity 50 Dysmenorrhea 50 QoL 50 acoustic startle 50 Blood Glucose 50 urodynamic 50 mRS 50 virologic breakthrough 50 Telcordia Granite 50 ERalpha 50 highest tertile 50 abdominal adiposity 50 FEV1 forced expiratory 50 Retreatment 50 ascending aortic 50 albumin excretion 50 flow mediated dilation 50 pulmonary artery pressure 50 preoperative PSA 50 epicardial adipose tissue 50 Bone Metastases 50 myocardial uptake 50 PsA 50 postoperative mortality 50 Cockcroft Gault 50 Index HAQ DI 50 -#.# ± [002] 50 postoperative complication 50 Significantly Improves 50 Quality Indicators 50 INVEGA ® 50 nausea dizziness vomiting 50 retrospective observational study 50 serum PSA 50 HDL Cholesterol 50 QT QTc 50 Autologous Stem Cell Transplantation 50 baseline HbA1c 50 venlafaxine XR 50 clinically meaningful improvements 50 corrected QT interval 50 dyspareunia 50 SpO 2 50 AUC0 #hr 50 Hepatitis C Genotype 50 Fasting Glucose 50 polysomnography PSG 50 affective psychoses 50 Dramatically Improves 50 #-#,# mg 50 Platelet Function 50 Erythema 50 ST Segment Elevation 50 multivariable logistic regression 50 euglycemic hyperinsulinemic clamp 50 hypopneas 50 Myocardial Infarction Study 50 urinary excretion 50 Menstrual Pain 50 polysomnographic 50 metabolic parameters 50 Hepatic Encephalopathy 50 Flesch Kincaid 50 inhaled budesonide 50 HbA1C levels 50 annualized relapse 50 Pearson correlation coefficients 50 androgen suppression 50 EDSS score 50 adrenocortical 50 PDSS 50 somatostatin analog 50 multivariate regression 50 analgesic efficacy 50 CIN2 + 50 P ≤ 50 PREZISTA r arm 50 Differential Diagnosis 50 somatic symptoms 50 serum prostate 50 Lowers Risk 50 myocardial viability 50 gastroduodenal 50 Systolic 50 Primary Endpoint 50 Eszopiclone 50 Modulates 50 serum IGF 50 attain statistical significance 50 Realized Volatility 50 serum lipid levels 50 r2 = 50 HbA 1c levels 50 psychopathological symptoms 50 chi squared 50 Attenuation 50 immunostaining 50 fractional anisotropy 50 Bioavailability 50 LATUDA 50 Strongly Linked 50 preintervention 50 PSADT 50 progression TTP 50 Preoperative 50 Viral load 50 mg XP# 50 QD dosing 50 carotid intima media 50 Score MOS 50 linear regression models 50 artery stenosis 50 ziprasidone 50 sensory disturbances 50 μg mL 50 Demonstrates Efficacy 50 Quantitation 50 trough FEV1 50 Mitotic 50 ARCALYST ® 50 DEXA scans 50 paraprotein 50 CYP#D# inhibitor 50 #.#dB [003] 50 p = #.# [003] 50 Major Depressive Disorder MDD 50 serum thyroglobulin 50 IIQ 50 mineral density 50 Abdominal Pain 50 L PPDS 50 secondary endpoint 50 SSRI SNRI 50 Non inferiority 50 pulmonary arterial 50 Mortality Risk 50 hip femoral neck 50 Histopathologic 50 clinical meaningfulness 50 O PPDS 50 lumen diameter 50 acamprosate calcium 50 Mental Component 50 Blepharospasm 50 psychophysiological